Merck Company Stock Today

MRK Stock  USD 103.09  0.46  0.44%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 6

 
High
 
Low
Low
Merck is selling for 103.09 as of the 9th of December 2024. This is a 0.44 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 102.69. Merck has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Note, on November 14, 2024, Representative Michael McCaul of US Congress acquired under $15k worth of Merck Company's common stock.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
13th of January 1978
Category
Healthcare
Classification
Health Care
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 2.53 B outstanding shares of which 26.32 M shares are now shorted by investors with about 2.6 days to cover. More on Merck Company

Moving together with Merck Stock

  0.88ME 23Andme HoldingPairCorr
  0.74VALN Valneva SE ADRPairCorr

Moving against Merck Stock

  0.84SABSW SAB BiotherapeuticsPairCorr
  0.82DRUG Bright Minds BiosciencesPairCorr
  0.69VERA Vera TherapeuticsPairCorr
  0.67VCYT VeracytePairCorr
  0.65VCEL Vericel Corp OrdPairCorr
  0.62VANI Vivani MedicalPairCorr

Merck Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanKenneth Frazier
Thematic Ideas
(View all Themes)
Old Names[Merck & Company Inc, Marka S.A., Merck & Company Inc, Merck & Company Inc]
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Dow Jones Industrial, NYSE Composite, DAX Index, NYSE 100 Index, SP 500 Index, SP 100 Index, SP 100, Dow Jones Composite, ARCA Pharmaceutical, ARCA Institutional, DAX Price, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, HDAX Performance, HDAX Price, Giant Impact, Robots And Drones, Compulsion, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.00330.0034
Notably Down
Pretty Stable
Asset Turnover0.730.5635
Significantly Up
Pretty Stable
Gross Profit Margin0.740.7317
Fairly Up
Slightly volatile
Total Current Liabilities13.3 B25.7 B
Way Down
Slightly volatile
Non Current Liabilities Total45.5 B43.3 B
Sufficiently Up
Slightly volatile
Total Assets60.3 B106.7 B
Way Down
Pretty Stable
Total Current Assets19.2 B32.2 B
Way Down
Pretty Stable
Total Cash From Operating Activities8.8 B13 B
Way Down
Slightly volatile
Debt Levels
Merck can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Merck's financial leverage. It provides some insight into what part of Merck's total assets is financed by creditors.
Liquidity
Merck Company has 36.27 B in debt with debt to equity (D/E) ratio of 0.68, which is OK given its current industry classification. Merck Company has a current ratio of 1.43, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Merck to invest in growth at high rates of return.

Begin Period Cash Flow

13.41 Billion
Merck Company (MRK) is traded on New York Stock Exchange in USA. It is located in 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 and employs 70,000 people. Merck is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 260.78 B. Merck Company runs under Pharmaceuticals sector within Health Care industry. The entity has 2.53 B outstanding shares of which 26.32 M shares are now shorted by investors with about 2.6 days to cover. Merck Company has about 12.69 B in cash with 13.01 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.44.
Check Merck Probability Of Bankruptcy
Ownership Allocation
Merck Company maintains a total of 2.53 Billion outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Company to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck Company. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or is about to change at the company. Please note that on November 14, 2024, Representative Michael McCaul of US Congress acquired under $15k worth of Merck Company's common stock.
Check Merck Ownership Details

Merck Stock Institutional Holders

InstituionRecorded OnShares
Legal & General Group Plc2024-09-30
23.6 M
T. Rowe Price Associates, Inc.2024-09-30
22.5 M
Deutsche Bank Ag2024-09-30
19.6 M
Charles Schwab Investment Management Inc2024-09-30
18.8 M
Bank Of New York Mellon Corp2024-09-30
18.7 M
Ubs Asset Mgmt Americas Inc2024-09-30
17.8 M
Ameriprise Financial Inc2024-09-30
17.2 M
Royal Bank Of Canada2024-09-30
16.6 M
Amundi2024-09-30
16.1 M
Vanguard Group Inc2024-09-30
249.8 M
Blackrock Inc2024-06-30
207.3 M
View Merck Diagnostics

Merck Historical Income Statement

At this time, Merck's EBITDA is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 43 B this year, although the value of Cost Of Revenue will most likely fall to about 11.7 B. View More Fundamentals

Merck Stock Against Markets

Merck Corporate Directors

Thomas GlocerLead Independent DirectorProfile
Christine SeidmanIndependent DirectorProfile
Kathy WardenIndependent DirectorProfile
Paul RothmanIndependent DirectorProfile
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.33)
Dividend Share
3.04
Earnings Share
4.78
Revenue Per Share
24.931
Quarterly Revenue Growth
0.044
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.